Is Congenital Anosmia Protective for Parkinson's Disease Triggered by Pathogenic Entrance Through the Nose?

Overview

Journal NPJ Parkinsons Dis

Date 2022 Nov 10

PMID 36357427

Authors

Artin Arshamian

Behzad Iravani

Johan N Lundstrom

Affiliations

Soon will be listed here.

Citing Articles

Opportunities and Pitfalls of REM Sleep Behavior Disorder and Olfactory Dysfunction as Early Markers in Parkinson's Disease.

Orso B, Brosse S, Frasnelli J, Arnaldi D J Parkinsons Dis. 2024; 14(s2):S275-S285.

PMID: 38517805 PMC: 11494648. DOI: 10.3233/JPD-230348.

Matters Arising: Is congenital anosmia protective for Parkinson's disease triggered by pathogenic entrance through the nose?.

Fjaeldstad A NPJ Parkinsons Dis. 2023; 9(1):94.

PMID: 37336891 PMC: 10279681. DOI: 10.1038/s41531-023-00538-5.

Reply to Matters Arising: Is congenital anosmia protective for Parkinson's disease triggered by pathogenic entrance through the nose?.

Arshamian A, Iravani B, Lundstrom J NPJ Parkinsons Dis. 2023; 9(1):95.

PMID: 37336882 PMC: 10279683. DOI: 10.1038/s41531-023-00539-4.

References

Silverstein S, Rosen R . Schizophrenia and the eye. Schizophr Res Cogn. 2015; 2(2):46-55. PMC: 4559409. DOI: 10.1016/j.scog.2015.03.004. View

Morgan V, Clark M, Crewe J, Valuri G, Mackey D, Badcock J . Congenital blindness is protective for schizophrenia and other psychotic illness. A whole-population study. Schizophr Res. 2018; 202:414-416. DOI: 10.1016/j.schres.2018.06.061. View

Haehner A, Boesveldt S, Berendse H, Mackay-Sim A, Fleischmann J, Silburn P . Prevalence of smell loss in Parkinson's disease--a multicenter study. Parkinsonism Relat Disord. 2009; 15(7):490-4. DOI: 10.1016/j.parkreldis.2008.12.005. View

Doty R . Olfaction in Parkinson's disease and related disorders. Neurobiol Dis. 2011; 46(3):527-52. PMC: 3429117. DOI: 10.1016/j.nbd.2011.10.026. View

Marras C, Goldman S, Smith A, Barney P, Aston D, Comyns K . Smell identification ability in twin pairs discordant for Parkinson's disease. Mov Disord. 2005; 20(6):687-93. DOI: 10.1002/mds.20389. View

Braak H, Del Tredici K, Rub U, de Vos R, Jansen Steur E, Braak E . Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2002; 24(2):197-211. DOI: 10.1016/s0197-4580(02)00065-9. View

Rey N, Wesson D, Brundin P . The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol Dis. 2016; 109(Pt B):226-248. PMC: 5972535. DOI: 10.1016/j.nbd.2016.12.013. View

Henriksson J, Tallkvist J, Tjalve H . Uptake of nickel into the brain via olfactory neurons in rats. Toxicol Lett. 1997; 91(2):153-62. DOI: 10.1016/s0378-4274(97)03885-x. View

Abolmaali N, Hietschold V, Vogl T, Huttenbrink K, Hummel T . MR evaluation in patients with isolated anosmia since birth or early childhood. AJNR Am J Neuroradiol. 2002; 23(1):157-64. PMC: 7975503. View

10.

Peter M, Martensson G, Postma E, Nordin L, Westman E, Boesveldt S . Morphological changes in secondary, but not primary, sensory cortex in individuals with life-long olfactory sensory deprivation. Neuroimage. 2020; 218:117005. DOI: 10.1016/j.neuroimage.2020.117005. View

11.

Marras C, Beck J, Bower J, Roberts E, Ritz B, Ross G . Prevalence of Parkinson's disease across North America. NPJ Parkinsons Dis. 2018; 4:21. PMC: 6039505. DOI: 10.1038/s41531-018-0058-0. View

12.

Sailani M, Jingga I, MirMazlomi S, Bitarafan F, Bernstein J, Snyder M . Isolated Congenital Anosmia and CNGA2 Mutation. Sci Rep. 2017; 7(1):2667. PMC: 5454015. DOI: 10.1038/s41598-017-02947-y. View

13.

Wenning G, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N . Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand. 1995; 91(4):247-50. DOI: 10.1111/j.1600-0404.1995.tb06998.x. View